Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0274 Transporter Info
Gene Name	SLC30A5
Transporter Name	Zinc transporter 5
Gene ID	64924
UniProt ID	Q8TAD4

Post-Translational Modification of This DT
Overview of SLC30A5 Modification Sites with Functional and Structural Information
Sequence	M E E K Y G G D V L A G P G G G G G L G P V D V P S A R L T K Y I V L L C F T K F L K A V G L F E S Y D L L K A V H I V Q F I F I L K L G T A F F M V L F Q K P F S S G K T I T K H Q W I K I F K H A V A G C I I S L L W F F G L T L C G P L R T L L L F E H S D I V V I S L L S V L F T S S G G G P A K T R G A A F F I I A V I C L L L F D N D D L M A K M A E H P E G H H D S A L T H M L Y T A I A F L G V A D H K G G V L L L V L A L C C K V G F H T A S R K L S V D V G G A K R L Q A L S H L V S V L L L C P W V I V L S V T T E S K V E S W F S L I M P F A T V I F F V M I L D F Y V D S I C S V K M E V S K C A R Y G S F P I F I S A L L F G N F W T H P I T D Q L R A M N K A A H Q E S T E H V L S G G V V V S A I F F I L S A N I L S S P S K R G Q K G T L I G Y S P E G T P L Y N F M G D A F Q H S S Q S I P R F I K E S L K Q I L E E S D S R Q I F Y F L C L N L L F T F V E L F Y G V L T N S L G L I S D G F H M L F D C S A L V M G L F A A L M S R W K A T R I F S Y G Y G R I E I L S G F I N G L F L I V I A F F V F M E S V A R L I D P P E L D T H M L T P V S V G G L I V N L I G I C A F S H A H S H A H G A S Q G S C H S S D H S H S H H M H G H S D H G H G H S H G S A G G G M N A N M R G V F L H V L A D T L G S I G V I V S T V L I E Q F G W F I A D P L C S L F I A I L I F L S V V P L I K D A C Q V L L L R L P P E Y E K E L H I A L E K I Q K I E G L I S Y R D P H F W R H S A S I V A G T I H I Q V T S D V L E Q R I V Q Q V T G I L K D A G V N N L T I Q V E K E A Y F Q H M S G L S T G F H D V L A M T K Q M E S M K Y C K D G T Y I M
PTM type	X-Acetylation X-Phosphorylation X-S-nitrosylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	759
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC30A5 Lysine 759 has the potential to affect its expression or activity.
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[2]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	1
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC30A5 Methionine 1 has the potential to affect its expression or activity.
Phosphorylation
Serine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	228
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Serine 228 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A5			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	378
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Serine 378 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A5			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	396
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Serine 396 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A5			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	398
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Serine 398 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC30A5			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	754
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Serine 754 has the potential to affect its expression or activity.
Threonine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	30
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Threonine 30 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A5			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	39
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Threonine 39 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A5			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	373
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Threonine 373 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A5			[4] , [8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	382
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Threonine 382 has the potential to affect its expression or activity.
Tyrosine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[9]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	5
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Tyrosine 5 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A5			[5]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	32
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Tyrosine 32 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A5			[4] , [10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	377
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Tyrosine 377 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A5			[4] , [11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	385
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Tyrosine 385 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC30A5			[7]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	757
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A5 Tyrosine 757 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[12]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	645
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC30A5 Cystine 645 has the potential to affect its expression or activity.
Ubiquitination
Alanine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[13]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	194
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Alanine 194 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A5			[14]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	330
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Alanine 330 has the potential to affect its expression or activity.
Asparticacid	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[14]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	326
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Asparticacid 326 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A5			[15]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	716
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Asparticacid 716 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[15]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	718
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Glycine 718 has the potential to affect its expression or activity.
Lysine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	89
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Lysine 89 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A5			[13]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	235
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Lysine 235 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A5			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	367
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Lysine 367 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A5			[17]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	371
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Lysine 371 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC30A5			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	404
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Lysine 404 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC30A5			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	666
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Lysine 666 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC30A5			[15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	759
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Lysine 759 has the potential to affect its expression or activity.
Phenylalanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[16]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	48
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Phenylalanine 48 has the potential to affect its expression or activity.
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A5			[15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	675
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A5 Serine 675 has the potential to affect its expression or activity.

References
1	Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J. 1995 Jun;14(6):490-4.
2	N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
3	Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
4	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
5	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
6	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
7	Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma. Mol Cell Proteomics. 2014 Apr;13(4):1034-49.
8	Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability. Mol Biol Cell. 2018 May 1;29(9):1031-1047.
9	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
10	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
11	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
12	Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
13	Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.
14	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
15	Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition. Mol Cell Proteomics. 2012 May;11(5):148-59.
16	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
17	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence